Related Experiment Video
Updated: Jan 13, 2026

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
17.0K
Precision Nanotechnology: Revolutionizing Therapeutic Strategies Against Drug-Resistant Breast Cancer
ZahraSadat Razavi1, Arefeh Mottaghi2, Lyudmila Dmitrieva3
1Physiology Research Center, Iran University Medical Sciences, Tehran, Iran. Farnaz.razavi@iau.ir.
Annals of Biomedical Engineering
|January 7, 2026
Summary
This study explores breast cancer drug resistance mechanisms like efflux pumps and cancer stem cells. Nanotechnology offers novel strategies to overcome resistance, improving treatment outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- Breast cancer drug resistance presents significant challenges due to mechanisms like ATP-binding cassette transporters, epithelial-to-mesenchymal transition (EMT), cancer stem cells (CSCs), immune evasion, and tumor microenvironment (TME) alterations.
- Understanding the molecular, cellular, and genetic underpinnings of these resistance mechanisms is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To comprehensively analyze the multifaceted mechanisms of breast cancer drug resistance.
- To investigate the potential of nanotechnology-based approaches in overcoming these resistance mechanisms.
- To bridge the gap between molecular insights into resistance and nanotechnological innovations for improved therapeutic outcomes.
Main Methods:
- Detailed analysis of molecular, cellular, and genetic contributors to drug resistance.
- Exploration of nanotechnology platforms including multifunctional nanocarriers, smart nanoparticle systems, and targeted drug delivery.
- Evaluation of specific nanocarriers like liposomes, micelles, and dendrimers for targeting CSCs and circumventing resistance pathways.
Main Results:
- Identification of key biological mechanisms driving breast cancer drug resistance.
- Demonstration of how nanotechnology can be engineered to target CSCs, bypass efflux pumps, modulate immune responses, and enhance treatment precision.
- Highlighting the application of liposomes, micelles, and dendrimers in overcoming specific resistance challenges.
Conclusions:
- Nanotechnology holds significant promise for overcoming diverse breast cancer drug resistance mechanisms.
- Targeted delivery systems and advanced nanocarriers can enhance therapeutic efficacy against resistant breast cancer.
- Further research and consideration of clinical translation and regulatory aspects are essential for implementing these nanotechnological innovations.
Related Concept Videos
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

